The sensitization spectrum to fungal allergens with atopic dermatitis and psoriasis in patients
DOI:
https://doi.org/10.46966/msjar.v4i2.130Keywords:
: Fungi, ELISA analyzer, allergen-specific IgE, AD and PSAbstract
The fungal allergy in the progress of atopic dermatitis (AD) and psoriasis (PS) are of special interest and determines the relevance in the study. The aim of the study to conduct a comparative analysis of the sensitization spectrum to fungal allergens in patients with atopic dermatitis and psoriasis. Materials and methods. The study involved patients with AD (Group I, n = 53) and PS (Group II, n=53) and aged group (15-60) years old. Sensitization to fungal allergens was determined by skin prick testing using standardized fungal allergens: Candida albicans, Alternaria alternata, Aspergillus fumigatus, Cladosporium herbarum, Penicillium notatum (ThermoFisher Scientific, Dubai). The concentration of allergen-specific IgE to a mixture of fungal allergens: Penicillium notatum, Cladosporium herbarum, Aspergillus fumigatus, Alternaria alternata (ThermoFisher Scientific, Dubai) were determined by indirect immunofluorescent analysis on a ELISA analyzer. The IgE level test of positive was considered in IgE level ≥ 0.35 kU/l. Results: The highest frequency of sensitization to fungi of the genus Cladosporium herbarum, Aspergillus fumigatus and Alternaria alternata were established In the group of patients with PS. The frequency of sensitization to fungi was higher in the group of patients with PS than in the group of patients with AD. Sensitization to a mixture of fungus allergens, according to the concentration of allergen-specific IgE, it were observed in the group of patients through compared with the group of patients in PS was : 2.7% and AD was 7.5%. Therefore, fungal allergy may play an important role in the etiopathogenesis of AD and PS. The study of the diagnosis and treatment of these pathologies, including a specific allergological examination of patients with AD and PS. To study of the genotyping of fungi causing human infection.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Hashim Alsherees

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















